622 material Form 8-K filings that 487 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
PTC Therapeutics director Alethia Young resigned from the board effective June 8, 2026, citing commitments to other work activities and not any disagreement with the company. She will remain as an advisor under a consulting agreement running through June 8, 2027, for a monthly fee of $4,166.67.
Alethia Young resigned from the board of directors effective June 8, 2026.
Resignation was stated to be due to her need to focus on other work commitments, not a disagreement with the company.
Consulting agreement runs June 8, 2026 through June 8, 2027, at $4,166.67 per month (Exhibit 10.1).
Teleflex's independent directors approved a special restricted stock unit award with a grant date fair value of $600,000 for Stuart A. Randle, who is serving as Interim President and Chief Executive Officer. The board said the award recognizes his work in that role, including operational, governance and investor relations matters and the company's search for a permanent CEO, and that he has served longer than initially expected.
Award: special restricted stock units with grant date fair value of $600,000 to Stuart A. Randle
Grant date: June 8, 2026; approved by independent directors on recommendation of the Compensation Committee
Vesting: earlier of June 8, 2027 or the date of the 2027 annual meeting of stockholders
Company is still searching for a permanent President and Chief Executive Officer
At its June 4, 2026 annual meeting, Talos Energy stockholders approved the Second Amended and Restated 2021 Long Term Incentive Plan, which adds 4,500,000 shares to the plan's share reserve and extends the plan term to the tenth anniversary of the meeting. Stockholders also elected six directors, approved executive pay on an advisory basis, and ratified Ernst & Young LLP as auditor. The larger share reserve means more shares can be issued under the plan, which can dilute existing holders.
Share reserve rises by 4,500,000 shares, from 12,439,415 to 16,939,415, subject to share recycling and adjustment provisions
Plan approved at the June 4, 2026 annual meeting and effective that day; term extended to the tenth anniversary of the meeting
Paula R. Glover's board term expired at the meeting, and the board was reduced from seven to six directors
Ernst & Young LLP ratified as independent auditor for the fiscal year ending December 31, 2026
At its June 9, 2026 annual meeting, Ulta Beauty stockholders elected all 10 director nominees, approved a new 2026 Incentive Award Plan, and approved amendments to the certificate of incorporation covering officer exculpation and exclusive forum provisions. The plan authorizes up to 5,001,201 shares, including 3,500,000 newly authorized shares, which shareholders should weigh as potential dilution. Most proposals passed with strong support, while the executive compensation advisory vote drew 22.02% against.
The 2026 Plan authorizes up to 5,001,201 shares: 3,500,000 new shares plus 1,501,201 remaining under the Prior Plan as of April 13, 2026.
Executive compensation advisory vote: 77.83% for, 22.02% against.
Ernst & Young LLP ratified as independent auditor for fiscal 2026, ending January 30, 2027, with 88.08% for.
Lorna E. Nagler and Gisel Ruiz received the lowest director support at 94.21% and 94.62% for, respectively.
Novanta agreed on June 8, 2026 to sell 2,142,857 common shares at $140.00 each in a private placement to institutional and accredited investors, for an aggregate purchase price of approximately $300.0 million before placement agent fees and expenses. The closing is expected on June 11, 2026, subject to customary conditions, and the company agreed to register the resale of the shares, which would add to the share count for existing holders.
Purchase price: $140.00 per share, 2,142,857 shares, about $300.0 million aggregate
Expected closing on or about June 11, 2026, subject to customary closing conditions
Post-closing count: 42,473,345 common shares outstanding or issuable under Tangible Equity Units, based on 35,613,303 shares outstanding as of June 8, 2026
Registration statement due within 30 days after closing; placement agents include J.P. Morgan Securities LLC and PNC Capital Markets LLC
Arch Capital Group completed a public offering of $2.0 billion in senior unsecured notes, split into $600 million due 2036 at 5.250% and $1.4 billion due 2056 at 5.950%. The notes add to the company's debt load, with interest paid semi-annually and the notes ranking behind obligations of its subsidiaries.
$600 million of 5.250% senior notes due June 15, 2036, and $1.4 billion of 5.950% senior notes due June 15, 2056
Interest is payable semi-annually on June 15 and December 15, starting December 15, 2026
Notes are effectively subordinated to obligations of the company's subsidiaries, including insurance and reinsurance policy obligations, and are not guaranteed by them
Notes were issued under a universal shelf registration on Form S-3 and a Third Supplemental Indenture dated June 9, 2026, with The Bank of New York Mellon as trustee
At its June 9, 2026 annual meeting, Innovative Industrial Properties stockholders approved a 2026 Omnibus Incentive Plan that replaces the 2016 plan, which has been terminated for new grants but still governs outstanding awards. The new plan allows up to 1,250,000 shares of common stock to be issued for awards, which matters to shareholders because it sets the share capacity for equity-based pay. Stockholders also elected five directors, ratified BDO USA as auditor, and gave a split vote on the advisory say-on-pay proposal.
The 2026 plan permits up to 1,250,000 common shares for awards, subject to adjustments and share counting rules.
Five directors were elected, including Alan Gold with 15,158,881 votes for and Scott Shoemaker with 10,281,923 votes for.
Advisory say-on-pay received 10,666,254 votes for and 6,025,986 votes against, and stockholders preferred a one-year frequency with 16,097,437 votes.
Casey's reported fourth-quarter diluted EPS of $4.37, up from $2.63 a year earlier, with net income of $162.7 million, driven by higher inside and fuel gross profit. For fiscal 2026, diluted EPS was $19.16 and EBITDA was nearly $1.5 billion, and the company guided fiscal 2027 EBITDA growth of 8% to 10%. The board also expanded the share repurchase authorization to $1 billion from $400 million, which bears directly on shareholder returns.
Q4 fiscal 2026 diluted EPS $4.37, up 66.2%; net income $162.7 million, up 65.5%
Fiscal 2026 diluted EPS $19.16, up 30.9%; net income $714.4 million, up 30.7%
Share repurchase authorization expanded to $1 billion from $400 million, effective June 4, 2026
Quarterly dividend raised 14% to $0.65 per share, payable August 14, 2026
Affiliated Managers Group entered a Fourth Amended and Restated Credit Agreement on June 9, 2026, providing a $1.25 billion senior unsecured revolving credit facility with Bank of America as administrative agent. It replaces the company's prior credit agreement dated November 15, 2024, and borrowings may fund general corporate purposes, including repurchases of common stock and cash dividends.
Facility size is $1.25 billion, maturing June 9, 2031
Company may increase commitments by up to $750 million, subject to conditions
Covenants include leverage and interest coverage financial tests, plus limits on priority debt, asset sales and fundamental changes
On June 8, 2026, Ingredion agreed with Tate & Lyle's board on a recommended all-cash acquisition of Tate & Lyle at 595 pence per share, with cash consideration of about £2.7 billion (about $3.6 billion) and an implied enterprise value of about $5.0 billion. Ingredion plans to fund the deal with existing cash, new debt and, if needed, a 364-day bridge loan, and expects pro forma net leverage of about 3.0x net debt-to-adjusted EBITDA at completion. The deal is expected to close in the second half of 2027, subject to Tate & Lyle shareholder and court approval and antitrust conditions, and Ingredion expects it to be adjusted EPS accretive in the first year.
Tate & Lyle shareholders would receive 595 pence in cash per share, about a 59% premium to the May 13, 2026 closing price.
Cash consideration is about £2.7 billion (about $3.6 billion); implied enterprise value is about £3.7 billion ($5.0 billion).
Ingredion expects pro forma net leverage of about 3.0x at completion and about 2.5x within about 18 months.
Expected run-rate net cost synergies of about $130 million by the end of 2030, against one-time costs of about $175 million.
On June 5, 2026, the company's operating partnership bought the Waterford Loan from NexBank Capital for $27.2 million, funded with borrowings under its revolving credit facility. The loan is a 10.00% fixed-rate term loan tied to the acquisition of a 240-unit multifamily property in North Carolina, and it marks the company's first deployment in its DST bridge-lending program. Because a director and officer of the company has ties to NexBank Capital and to the external adviser, the deal is a related-party transaction.
Purchase price of $27.2 million equal to outstanding principal plus accrued interest, funded through the revolving credit facility with JPMorgan Chase Bank, N.A.
Fixed interest rate of 10.00% per year, compounded monthly, with a stated maturity of January 14, 2028 and a 364-day extension option.
Loan bought without recourse except for breaches of representations; NexBank Capital must repurchase it if a material breach is not cured within 30 days, and claims survive 360 days.
A director and officer is a director of NexBank Capital and is linked to the parent of the external adviser, NexPoint Real Estate Advisors, L.P.
Cracker Barrel reported fiscal third-quarter 2026 revenue of $797.4 million, down 2.9% from a year earlier, and GAAP diluted earnings of $1.90 per share, which include a $47.4 million litigation settlement benefit. Excluding non-GAAP adjustments, adjusted diluted earnings were $0.29 per share versus $0.58 a year earlier, and adjusted EBITDA was $40.3 million versus $48.1 million. The company raised its fiscal 2026 revenue and adjusted EBITDA outlook, which is the main positive for shareholders.
Q3 total revenue $797.4 million, down 2.9%; comparable store restaurant sales down 2.6%
GAAP diluted EPS $1.90 vs $0.56; adjusted diluted EPS $0.29 vs $0.58
Fiscal 2026 adjusted EBITDA outlook raised to $120 million to $125 million from $85 million to $100 million
Fiscal 2026 revenue outlook raised to $3.27 billion to $3.30 billion from $3.24 billion to $3.27 billion
Wendy's Chief Accounting Officer Suzanne Thuerk has given notice she will resign to pursue an opportunity outside the restaurant industry. Vice President – Tax Aaron Kale was appointed Chief Accounting Officer and principal accounting officer effective June 8, 2026, and Thuerk will stay on in a non-executive role until July 10, 2026 to support the handover.
Suzanne M. Thuerk gave notice of resignation on June 4, 2026, to pursue an opportunity outside the restaurant space.
Aaron M. Kale, age 49, was appointed Chief Accounting Officer and Vice President – Tax effective June 8, 2026.
Kale has been Vice President – Tax since April 2019 and has provided interim leadership of the accounting function since July 2025.
Thuerk will remain with the company in a non-executive capacity until July 10, 2026.
At its June 9, 2026 annual meeting, Stifel Financial shareholders elected all twelve directors, approved an increase in authorized shares from 197,000,000 to 294,000,000, and approved adding 9,000,000 shares to the 2001 Incentive Stock Plan. The filing does not state the reasons for the share increases, but the authorized share increase and larger plan capacity could affect existing shareholders' ownership percentage if the shares are issued.
Authorized total shares rose from 197,000,000 to 294,000,000; common authorized shares rose from 194,000,000 to 291,000,000
Incentive Stock Plan capacity increased by 9,000,000 shares, including 175,000 reserved for non-employee directors, with 87,433,331 votes for and 38,926,563 against
Shareholders approved advisory say-on-pay, with 123,866,225 votes for and 2,396,358 against, and ratified KPMG LLP for 2026
On June 9, 2026, Micron's board appointed Alexis Black Björlin as an independent director and as a member of the Governance and Sustainability Committee. After the appointment, the board has nine directors, eight of them independent under Nasdaq rules. The filing discloses her director compensation but no financial results or other business effects.
Appointed to the board on June 9, 2026; the board now has nine directors, eight independent.
Joins the Governance and Sustainability Committee.
Compensation under the 2025 Director Compensation Plan includes a pro rata cash retainer for board service of $125,000 and a pro rata restricted stock grant valued at $250,000.
Currently Chief Strategy Officer at General Catalyst; previously senior vice president and general manager of DGX Cloud at NVIDIA.
Hershey's board appointed Joe Park, executive vice president and chief digital and information officer at State Farm, as a director effective June 29, 2026. The board determined he is independent under NYSE standards and he will sit on the Audit and Finance and Risk Management Committees.
Board appointment approved June 3, 2026, on the recommendation of the Governance Committee; effective June 29, 2026
Park has over 20 years of experience in digital transformation and technology strategy, including senior roles at Yum! Brands and Walmart
Park will join the Audit and Finance and Risk Management Committees and receive standard non-employee director compensation
Grocery Outlet appointed Ian Ferry as Executive Vice President, Chief Financial Officer and Treasurer, effective June 9, 2026, succeeding Christopher Miller, who leaves June 26, 2026. The company also named Paul Miller Executive Vice President, Chief Purchasing and Merchandising Officer, replacing Matthew Delly, who departs June 12, 2026, and affirmed its second quarter and fiscal 2026 outlook first provided May 13, 2026. The finance and purchasing leadership changes matter to shareholders because they reshape two senior roles, while the outlook was reaffirmed rather than changed.
Ian Ferry, 45, joined in June 2025 and becomes CFO with a $475,000 base salary and a target bonus of 60% of base salary.
Christopher Miller's departure is effective June 26, 2026; Matthew Delly's is effective June 12, 2026.
Paul Miller, a former Grocery Outlet executive who retired in 2024, returns full-time after serving as an advisor.
Susan Leary was promoted to Senior Vice President, Accounting and designated Principal Accounting Officer, with a $300,000 base salary.
Capital One filed a prospectus supplement that adds 39,843 shares of common stock to the resale registration for selling security holders who received them as consideration for the Brex Inc. acquisition, which closed April 7, 2026. The total shares the selling holders may offer rises to 10,385,749 from 10,345,906 previously. The filing is administrative and adds a modest number of shares that could enter the market.
Resale Prospectus Supplement No. 2 is dated June 9, 2026 and adds 39,843 shares.
Total registered for resale rises to 10,385,749 shares from 10,345,906 under the April 23, 2026 supplement.
Shares were issued to selling security holders as consideration for the Brex Inc. acquisition, which closed April 7, 2026.
On June 8, 2026, Virtu Financial Operating LLC, a subsidiary of Virtu Financial, Inc., entered into an amended and restated employment agreement with Chief Financial Officer Cindy Lee. The filing sets her base salary at $500,000 per year, adds a 20,000-share restricted stock or RSU special award, and sets severance terms that increase if a change in control occurs.
Base salary of $500,000 per year, with eligibility for a discretionary annual bonus
Special award of 20,000 restricted shares or RSUs, vesting in three equal annual installments
Initial term expires June 30, 2029, with automatic one-year renewals unless either party gives notice at least 90 days in advance
After a qualifying termination tied to a change in control, severance equals two and a half times base salary plus the most recent annual bonus, and benefits continue for 24 months or longer
At its June 5, 2026 annual meeting, Ligand Pharmaceuticals stockholders elected all eight director nominees to terms expiring in 2027 and approved an amended and restated 2002 Stock Incentive Plan. Stockholders also ratified Ernst & Young LLP as auditor for fiscal 2026 and approved a non-binding advisory vote on executive pay. The filing reports voting results only and does not report financial results.
All eight director nominees were elected, including Jason M. Aryeh, Todd C. Davis and Martine Zimmermann, Pharm.D.
Proposal 4 to approve the amended and restated 2002 Stock Incentive Plan passed with 16,643,281 votes for and 870,556 against.
Ernst & Young LLP was ratified as independent registered public accounting firm for the year ending December 31, 2026, with 18,526,515 votes for.
Non-binding say-on-pay proposal was approved with 16,497,712 votes for and 1,021,948 against.
STAAR Surgical's Compensation Committee approved a base salary increase for Deborah Andrews, its Interim Co-Chief Executive Officer and Chief Financial Officer, from $512,000 to $575,000, effective June 8, 2026. The committee also raised her target annual cash bonus from 55% to 60% of base salary, citing a review of competitive market pay data and her contributions to strategic and operational objectives.
Base salary rises from $512,000 to $575,000, effective June 8, 2026
Target annual cash bonus increases from 55% to 60% of base salary
Committee cited competitive market compensation data and Ms. Andrews' contributions to company objectives
Sherwin-Williams amended its credit agreement with Goldman Sachs Bank USA as administrative agent. The primary purpose is to extend the maturity of $200 million of borrowing and letter of credit commitments from June 20, 2026 to June 20, 2031.
Amendment No. 11 was entered into on June 9, 2026 with Goldman Sachs Bank USA as administrative agent and Goldman Sachs Mortgage Company as issuing bank.
$200 million of commitments now mature June 20, 2031, up from June 20, 2026.
The filing states that certain lenders and their affiliates have provided and may provide other financial services to the company, for which they receive customary fees.
Academy Sports and Outdoors reported first-quarter fiscal 2026 net sales of $1.44 billion, up 6.7%, and GAAP diluted EPS of $0.80, up 17.6%. The company raised the low end of its full-year guidance, lifting GAAP diluted EPS to $5.95 to $6.35 from $5.65 to $6.15, which benefits shareholders while management says it expects inflationary pressures to continue weighing on consumer spending.
Q1 net sales of $1.44 billion, up 6.7%; comparable sales up 2.9%
Q1 GAAP diluted EPS of $0.80, up 17.6%; adjusted diluted EPS of $0.93, up 22.4%
FY2026 GAAP diluted EPS guidance raised to $5.95-$6.35 from $5.65-$6.15; adjusted EPS guidance raised to $6.40-$6.80 from $6.10-$6.60
Quarterly dividend of $0.15 per share declared June 4, 2026, payable July 16, 2026 to holders of record on June 18, 2026
J.M. Smucker reported fourth-quarter fiscal 2026 net sales of $2.3 billion, up 6%, and adjusted earnings per share of $2.77, up 20%. For the full fiscal year, adjusted EPS fell 10% to $9.15 and the company posted a net loss of $1.30 per diluted share, while it guided fiscal 2027 net sales down 3.0% to 4.0% and adjusted EPS of $9.75 to $10.25.
Q4 net sales $2.3 billion (about $2,268.1 million), up 6%; adjusted EPS $2.77 vs. $2.31 a year earlier.
Q4 GAAP net income $3.64 per diluted share, compared with a net loss of $6.85 in the prior-year quarter, which included $867.3 million of goodwill impairment charges.
Fiscal 2026 net sales $9.1 billion, up 4%; net loss of $1.30 per diluted share; adjusted EPS $9.15, down 10%.
Fiscal 2027 outlook: net sales down 3.0% to 4.0%, adjusted EPS $9.75 to $10.25, free cash flow about $1.0 billion.
UNFI reported third-quarter fiscal 2026 results for the 13 weeks ended May 2, 2026. Net sales fell 4.2% to $7.7 billion, which the company said included about 450 basis points of impact from optimization actions, while net income rose to $33 million from a $7 million loss a year earlier. The company reiterated its full-year fiscal 2026 outlook midpoints and narrowed the ranges, and reported net leverage of 2.5x.
Net sales decreased 4.2% to $7.7 billion, including about 450 basis points of impact from optimization actions
Net income of $33 million, or $0.52 per diluted share, versus a net loss of $7 million, or $0.12 per share, a year earlier
Adjusted EBITDA rose 16.6% to $183 million; free cash flow was $54 million versus $119 million
Fiscal 2026 outlook midpoints reiterated for net sales, net income, EPS, Adjusted EBITDA and Adjusted EPS, with ranges narrowed
Novanta agreed on June 8, 2026 to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion in cash at closing, plus a $250 million milestone payment due by January 8, 2027. The deal is funded with cash on hand, existing credit facilities and a $300 million equity raise, and the credit agreement was amended to raise the permitted leverage ratio, which means more debt for shareholders to carry. The company expects the deal to close in the third quarter of 2026 and says it will update guidance after closing.
Purchase price of $1.2 billion in cash at closing, subject to customary adjustments, plus a $250 million milestone payment due on or before January 8, 2027
Financing from cash on hand, existing credit facilities and a recently completed $300 million equity raise
Credit agreement amended: permitted consolidated leverage ratio raised to 4.00 to 1.00, or 4.50 to 1.00 for four quarters after a designated acquisition
Expected net leverage of about 2.7x at closing in the third quarter of 2026, with a target below 2.3x by year-end 2027; standalone 2026 guidance was confirmed
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.